The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro

Endocrinology (2003) - Comment
pubmed: 12960029 doi: 10.1210/en.2003-0705 issn: 0013-7227 issn: 1945-7170

J. M. W. Gee, M. E. Harper, I. R. Hutcheson, T. A. Madden, D. Barrow, J. M. Knowlden, R. A. McClelland, N. Jordan, A. E. Wakeling, R. I. Nicholson